Follow
Akashdip Singh
Akashdip Singh
PhD student, UMC Utrecht
Verified email at umcutrecht.nl
Title
Cited by
Cited by
Year
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction
MIP Ramos, L Tian, EJ de Ruiter, C Song, A Paucarmayta, A Singh, ...
Elife 10, e62927, 2021
482021
Collagen fragments produced in cancer mediate T cell suppression through leukocyte-associated immunoglobulin-like receptor 1
SV Vijver, A Singh, ETAM Mommers-Elshof, J Meeldijk, R Copeland, ...
Frontiers in Immunology 12, 733561, 2021
322021
Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice
A Singh, ETAM Mommers-Elshof, SV Vijver, JH Jansen, S Gonder, ...
Cancer Immunology, Immunotherapy 73 (1), 1-14, 2024
2024
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
A Singh, A Miranda Bedate, HJ von Richthofen, M van der Vlist, R Kuhn, ...
bioRxiv, 2023.10. 24.563834, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–4